Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,196 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05670691 | a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy | unknown | — | 71 | Fudan UniversityOTHER | 0 | Jan 11, 2023 | clinicaltrials |
| NCT05674305 | Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy | recruiting | Phase 3 | 366 | Fudan UniversityOTHER | 1 | Jan 10, 2023 |
| clinicaltrials |
| NCT05663021 | Feasibility in Identification of Breast Cancer Candidates for Elimination of Axillary Surgery | completed | N/A | 191 | Fudan UniversityOTHER | 1 | Dec 23, 2022 | clinicaltrials |
| NCT05645094 | Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer | unknown | — | 38 | Fudan UniversityOTHER | 0 | Dec 13, 2022 | clinicaltrials |
| NCT04001621 | Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05643417 | Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy | unknown | Phase 1 | 80 | Fudan UniversityOTHER | 1 | Dec 8, 2022 | clinicaltrials |
| NCT05638243 | Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program(METHOD-3) | unknown | — | 10,000 | Fudan UniversityOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT05638984 | Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 0 | Dec 6, 2022 | clinicaltrials |
| NCT05633641 | Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma | unknown | — | 60 | Fudan UniversityOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05634590 | The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05635630 | Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention | unknown | N/A | 110 | Fudan UniversityOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05628922 | Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT | recruiting | Phase 2 | 198 | Fudan UniversityOTHER | 1 | Nov 29, 2022 | clinicaltrials |
| NCT05627310 | Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images | unknown | — | 50,000 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT05359393 | A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis(Miracle-1) | not yet recruiting | Phase 2 | 52 | Fudan UniversityOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05614375 | Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus | unknown | — | 40 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05406466 | Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis | unknown | Phase 2 | 25 | Fudan UniversityOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT05602831 | Assessment of Prognosis Using Peripheral Blood Circulating Tumor DNA in Patients With Cervical Cancer | unknown | — | 108 | Fudan UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05478460 | Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung Cancer | completed | — | 161 | Fudan UniversityOTHER | 1 | Oct 24, 2022 | clinicaltrials |
| NCT05577923 | Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) | unknown | Phase 2 | 126 | Fudan UniversityOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT04984070 | Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety(PCOS) | unknown | N/A | 100 | Fudan UniversityOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT05545254 | Health-promoting Lifestyle in a Genetic Counseling Clinic | completed | — | 140 | Fudan UniversityOTHER | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05540951 | VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer | unknown | Phase 3 | 78 | Fudan UniversityOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT05537129 | Laparoscopic vs Open Total Gastrectomy for Gastric Cancer | recruiting | N/A | 600 | Fudan UniversityOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT05510037 | Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions | completed | — | 1,299 | Fudan UniversityOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT02526043 | Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma | unknown | N/A | 180 | Fudan UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04782804 | Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04856761 | A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection | unknown | — | 160 | Fudan UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04974281 | PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC | unknown | Early Phase 1 | 50 | Fudan UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05498805 | PD-1 Inhibitors With or Without Radiation in Advanced Melanoma | unknown | Phase 2 | 92 | Fudan UniversityOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03805399 | FUSCC Refractory TNBC Umbrella (FUTURE)(FUTURE) | unknown | Phase 1 / Phase 2 | 140 | Fudan UniversityOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT05489848 | Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation | not yet recruiting | Phase 2 / Phase 3 | 294 | Fudan UniversityOTHER | 0 | Aug 5, 2022 | clinicaltrials |
| NCT05255406 | Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE) | unknown | Phase 2 | 62 | Fudan UniversityOTHER | 1 | Aug 4, 2022 | clinicaltrials |
| NCT03838796 | Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma | unknown | N/A | 297 | Fudan UniversityOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT05483543 | Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy | unknown | Phase 2 | 44 | Fudan UniversityOTHER | 1 | Aug 2, 2022 | clinicaltrials |
| NCT04903665 | PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I | unknown | — | 495 | Fudan UniversityOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT05475847 | Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer(TIL) | unknown | Phase 1 | 20 | Fudan UniversityOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT04520074 | Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) | recruiting | Phase 3 | 590 | Fudan UniversityOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04355858 | Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer(MULAN) | unknown | Phase 2 | 319 | Fudan UniversityOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT04297267 | A Study to Evaluate Gemcitabine Plus Cisplatin in the Treatment of TNBC Patients Following Neoadjuvant Chemotherapy(nonpCR GP) | unknown | Phase 2 | 100 | Fudan UniversityOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT05462470 | Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis | completed | — | 255 | Fudan UniversityOTHER | 0 | Jul 19, 2022 | clinicaltrials |
| NCT05451719 | Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy | unknown | Phase 2 | 116 | Fudan UniversityOTHER | 0 | Jul 12, 2022 | clinicaltrials |
| NCT00677586 | Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-limited Metastasis | completed | N/A | 180 | Fudan UniversityOTHER | 0 | Jul 7, 2022 | clinicaltrials |
| NCT04850625 | Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine | completed | — | 224 | Fudan UniversityOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05432219 | A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma | unknown | N/A | 20 | Eye & ENT Hospital of Fudan UniversityOTHER | 0 | Jun 27, 2022 | clinicaltrials |
| NCT03792932 | Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer | unknown | N/A | 306 | Fudan UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05426850 | ctDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma | unknown | — | 100 | Fudan UniversityOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05420597 | Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma | unknown | Phase 2 | 61 | Fudan UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT01307878 | New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases | completed | Phase 3 | 320 | Fudan UniversityOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT05303038 | Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy(Castle06(BC)) | unknown | Phase 2 | 15 | Fudan UniversityOTHER | 1 | Jun 9, 2022 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials